Product Information
GEMTESA 75 MG TABLET is a brand product labeled by Sumitomo Pharma America, Inc., priced at $16.4635 per EA under NDC 73336007590. Its NADAC has been published 209 times since Jun 29, 2022.
Strength
75 mg/1
Manufacturer
Sumitomo Pharma America, Inc.NDC
73336007590
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VIBEGRONApproval Type
New Drug (NDA)
FDA Application
NDA213006On Market Since
12/29/2020
Pharmacological Classes
Price Statistics
The NADAC for GEMTESA 75 MG TABLET has been published 209 times since Jun 29, 2022, and over the history we have for it it has risen 12.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.4635 per EA |
|---|---|
| All-time high | $16.4726 (May 13, 2026) |
| All-time low | $14.6676 (Jun 29, 2022) |
| 52-week high | $16.4726 |
| 52-week low | $15.9786 |
| Median price | $15.5488 |
| Average price | $15.5361 |
| Largest weekly change | +3.0% (Jan 14, 2026) |
| Weeks tracked | 209 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GEMTESA 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GEMTESA 75 MG TABLET, manufactured by Sumitomo Pharma America, Inc., is $16.4635 per EA (NDC 73336007590), effective Jun 24, 2026.
How has the price of GEMTESA 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for GEMTESA 75 MG TABLET has risen 12.2%. It has been tracked across 209 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for GEMTESA 75 MG TABLET?
Since Jun 29, 2022, the NADAC for GEMTESA 75 MG TABLET has ranged from a low of $14.6676 (Jun 29, 2022) to a high of $16.4726 (May 13, 2026), with a median of $15.5488 per EA.
Are there cheaper alternatives to GEMTESA 75 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as GEMTESA 75 MG TABLET, but none are currently priced below it.
Who manufactures GEMTESA 75 MG TABLET?
GEMTESA 75 MG TABLET (NDC 73336007590) is labeled by Sumitomo Pharma America, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification